Actively Recruiting
Study of Gut Microbiome Changes in Adults With Post-Infectious Irritable Bowel Syndrome Using Whole Genome Sequencing
Led by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Updated on 2026-04-13
315
Participants Needed
1
Research Sites
8 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the gut microbiome in adults with post-infectious irritable bowel syndrome PI-IBS, a condition that develops after an acute gastrointestinal infection. This observational, multicenter, prospective study aims to identify specific microbial patterns linked to PI-IBS by comparing affected patients with two control groups individuals recovered from infection without IBS and healthy subjects. The goal is to find consistent microbial signatures related to disease presence and symptom severity, supporting future microbiome-based treatments. The study will enroll 315 adults, including 105 PI-IBS patients diagnosed within three months, 105 post-infectious controls without IBS diagnosed more than six months ago, and 105 healthy controls. PI-IBS patients will have clinical evaluations and stool samples collected at baseline and monthly for three months. Control groups will provide a single stool sample and related lifestyle information at enrollment. Stool samples will be processed uniformly and analyzed using whole genome sequencing to profile microbiome composition and function. Participants will complete symptom assessments, medical history reviews, and lifestyle questionnaires. Researchers will analyze the microbiome data to identify differences between groups and associations with symptom severity using advanced statistical and machine learning methods. The primary outcome is finding microbial signatures distinguishing PI-IBS patients from controls over up to 30 months. Secondary outcomes include correlations between microbiome features and disease severity. This research will inform future precision microbiome therapies for PI-IBS.
CONDITIONS
Brief Title
Gut Microbiome in Patients With Post-infectious Irritable Bowel Syndrome
Research Team
G
Gianluca Ianiro
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here